Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...

Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

In spite of its sustainable moat, Palantir Technologies is butting heads with historical headwinds that have a flawless track ...

Union momentum grows in Ireland’s €100bn pharma sector as Trump’s tariff threats and weak labour laws fuel worker unrest ...

In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the ...

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.

Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

The Minister for Health, Kwabena Mintah Akandoh, has met with Mr. Ali Besri, Head of Pfizer's Accord and his team, to strengthen collaboration in advancing equitable and affordable healthcare in Ghana ...

With the largest defense budget in the world, the United States spares no expense to make sure it has the largest military ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...